Search

Showing total 3,329 results

Search Constraints

Start Over You searched for: Topic leishmaniasis Remove constraint Topic: leishmaniasis
3,329 results

Search Results

201. N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice.

202. Multi-sensorial perceptions of risk: the aesthetics behind (muco)cutaneous leishmaniasis-related stigma in Ecuador.

203. DYNAMICS OF VISCERAL LEISHMANIA EPIDEMIC MODEL WITH NON-SINGULAR KERNEL.

204. Third Case of Visceral Leishmaniasis in COVID-19: Mini Review Article.

205. کاربرد گیاهان دارويی در درمان بیماری انگلی لیشمانیوز: يک مطالعه مروری دامنهای.

206. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.

207. Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity.

208. MEDICINSKI ZNAČAJ PROTOZOA USNE DUPLJE U STOMATOLOŠKOJ PRAKSI.

209. Placing Leishmaniasis in the Limelight through the Communicable Disease Surveillance System: An Experience from Sri Lanka.

210. Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships.

211. Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: cluster randomised trial

212. Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents.

213. Spatial analysis of leishmaniasis in Brazil: a systematized review.

214. Leishmaniasis in Cameroon: what is known and is done so far? A protocol for systematic review.

215. Computational System Level Approaches for Discerning Reciprocal Regulation of IL10 and IL12 in Leishmaniasis.

216. Transmission patterns of Leishmania tropica around the Mediterranean basin: Could Morocco be impacted by a zoonotic spillover?

217. Evaluation of the direct agglutination test based on freeze-driedLeishmania donovanipromastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.

218. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.

219. Attraction and oviposition preferences of Phlebotomus papatasi (Diptera: Psychodidae), vector of Old-World cutaneous leishmaniasis, to larval rearing media.

220. Evaluation of conventional and four real-time PCR methods for the detection of Leishmania on field-collected samples in Ethiopia.

221. Glasgow encounters with tropical diseases.

222. Evolution of chromone-like compounds as potential antileishmanial agents, through the 21 st century.

223. A Feasibility Study on Using the Facilities of Health Centers for Developing a Laboratory Network on Vectors and Reservoir Hosts of Cutaneous Leishmaniasis in Iran.

225. Could combination chemotherapy be more effective than monotherapy in the treatment of visceral leishmaniasis? A systematic review of preclinical evidence.

226. Landscape effects on the abundance of Lutzomyia longipalpis and Migonemyia migonei (Diptera: Psychodidae: Phlebotominae) in Corrientes city, northern Argentina.

227. Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.

228. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis.

229. A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization.

230. Leishmania infantum infection reduces the amyloid β 42 -stimulated NLRP3 inflammasome activation.

231. Respiratory Diseases, Malaria and Leishmaniasis: Temporal and Spatial Association with Fire Occurrences from Knowledge Discovery and Data Mining.

232. Monitoring Leishmania infection and exposure to Phlebotomus perniciosus using minimal and non-invasive canine samples.

233. Leishmania infection in cats positive for immunodeficiency virus and feline leukemia virus in an endemic region of Iran.

234. Biogenic metal nanoparticles as a potential class of antileishmanial agents: mechanisms and molecular targets.

235. Synthesis, crystal structure and leishmanicidal activity of new trimethoprim Ru(III), Cu(II) and Pt(II) metal complexes.

236. Toll-Like Receptors 2, 4, and 7, Interferon-Gamma, Interleukin 10, and Programmed Death Ligand 1 Transcripts in Leishmanin Skin Test-Positive Reactions of Ibizan Hound Dogs.

237. The spatial and temporal distribution, species composition, and host preference of phlebotomine sand flies in the Bethlehem District of Palestine.

238. Novel indol-3-yl-thiosemicarbazone derivatives: Obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies.

239. Structural sequence evolution and computational modeling approaches of the complement system in leishmaniasis.

241. Spatial analysis of leishmaniasis in Brazil: a systematized review.

242. Current Visceral Leishmaniasis Research: A Research Review to Inspire Future Study.

243. Geographic and ecological features of phlebotomine sand flies (Diptera: Psychodidae) as leishmaniasis in Central Iran.

244. Brain Parenchyma (pons) Involvement by Visceral Leishmaniasis: A Case Report.

245. Impact of the dog population and household environment for the maintenance of natural foci of Leishmania infantum transmission to human and animal hosts in endemic areas for visceral leishmaniasis in Sao Paulo state, Brazil.

246. Molecular detection of Leishmania donovani, Leishmania major, and Trypanosoma species in Sergentomyia squamipleuris sand flies from a visceral leishmaniasis focus in Merti sub-County, eastern Kenya.

247. Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials.

248. Determination of fauna and seasonal activity of phlebotomine sandflies (Diptera: Psychodidae: Phlebotominae) as vectors of disease agents in Southwestern Iran.

249. Biochemical identification of cutaneous leishmanias by analysis of kinetoplast DNA. II. Sequence homologies in Leishmania kDNA

250. Evaluation of Change in Canine Diagnosis Protocol Adopted by the Visceral Leishmaniasis Control Program in Brazil and a New Proposal for Diagnosis.